Abiopharma

COGNEX CORP (CGNX)

Symbol	CGNX
Name	COGNEX CORP
Sector	INDUSTRIALS
Region	North America
Industry	Industrial Instruments For Measurement, Display, and Control
Address	ONE VISION DR, NATICK, MA 01760
Telephone	5086503000
Fax	—
Email	—
Website	https://www.cognex.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0000851205
Description	Cognex Corp provides machine vision products that help automate manufacturing processes. The firms products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customers own cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. ID products read codes that have been applied to items during the manufacturing process. Cognex generates the largest proportion of its sales in the United States and Europe. Additional info from NASDAQ: Cognex Corp provides machine vision products that help automate manufacturing processes. The firms products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customers own cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. ID products read codes that have been applied to items during the manufacturing process. Cognex generates the largest proportion of its sales in the United States and Europe.

2026-09-02 12:01

Cognex Corporation - Cognex to Present at the Morgan Stanley 14th Annual Laguna Conference

2026-09-02 12:00

Cognex to Present at the Morgan Stanley 14th Annual Laguna Conference

2026-08-12 20:00

Director Moschner Matthew 🟡 adjusted position in 788.0K shares (17 derivative) of COGNEX CORP (CGNX) at $86.38 ($28.5M) Transaction Date: Aug 11, 2026 | Filing ID: 000008

2026-08-11 20:31

📋 MATTHEW MOSCHNER (Director) plans to sell 25K shares of COGNEX CORPORATION (at $64.36 each, total $1.6M) Filed: Aug 11, 2026 | ID: 007967

2026-08-11 20:22

Long Darren Marc 🟡 adjusted position in 163.0K shares (11 derivative) of COGNEX CORP (CGNX) at $66.89 ($6.2M) Transaction Date: Aug 07, 2026 | Filing ID: 000006

2026-08-11 20:18

Director Moschner Matthew 🟡 adjusted position in 781.8K shares (18 derivative) of COGNEX CORP (CGNX) at $86.38 ($26.3M) Transaction Date: Aug 07, 2026 | Filing ID: 000006

2026-08-05 20:30

Cognex Corporation - Cognex Reports Second Quarter 2026 Results

2026-08-05 20:30

Cognex Reports Second Quarter 2026 Results

2026-07-29 12:01

Cognex Corporation - Cognex to Present at the KeyBanc Technology Leadership Forum

2026-07-29 12:00

Cognex to Present at the KeyBanc Technology Leadership Forum